About CoAxia
CoAxia is a Healthcare company based in Maple Grove (United States) founded in 1999, and was acquired by ZOLL AEDs in July 2013. Catheter-based treatment for cerebral ischemia. CoAxia has raised $72.6 million across 4 funding rounds from investors including ZOLL AEDs, Canaan and Sofinnova. The company was acqui-hired. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity is CoAxia, Inc. Its competitors include Sequent Medical and Metactive Medical; 2 of its 2 listed competitors have raised funding.
Company details
CoAxia was developing catheter-based perfusion augmentation therapies to improve outcomes for patients with cerebral ischemia. The core application for CoAxias catheter technology, under the trade names NeuroFlo and FloControl, involves the redistribution of blood flow from the lower extremities to support brain function during ischemia. Acquired by Zoll, an Asahi Kasei Group company in 2013.
- Headquarters Maple Grove, United States
- Stage Acquired
- SectorsHealthcare
- Website coaxia.com
- Acquired by ZOLL AEDs (Jul 2013)
- Legal Name Coaxia, Inc
Funding Insights of CoAxia
CoAxia has successfully raised a total of $72.6M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $22.5 million completed in March 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $72.6M
- Total Rounds 4
- Last Round Series D — $22.5M
- First Round $17.6M
(Jun 2004)
- Investors Count 6
All 4 funding rounds of CoAxia with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2011 | $22.5M | Series D | – | – | – |
| Jun 2009 | $21.5M | Series D | – | – | |
| Sep 2006 | $11M | Series C | – | – | |
| Jun 2004 | $17.6M | Series B | – | – |
7 investors in total: 7 institutional.
Investors in CoAxia
CoAxia has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include ZOLL AEDs, Canaan and Sofinnova.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biotech funding, drug development support, and investment in life sciences. | sofinnova.com | |||
| affinitycapitalmanagement.com | ||||
Canaan is recognized as an early-stage venture capital firm. | 1987 | canaan.com | San Francisco, United States | |
Venture capital firm backed by Johnson & Johnson | jnjinnovation.com/jjdc | Cambridge, United States | ||
VC firm investing in the US | prismventure.com | Westwood, United States | ||
Global private equity and venture capital investments in B2B Tech & Services companies. | bairdcapital.com | |||
Medical devices and software for emergency care are developed. | 1983 | zoll.com | Chelmsford, United States |
Investor details for CoAxia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CoAxia
1 people are tracked at CoAxia (1 in leadership).
| Name | Role | Group |
|---|---|---|
Joyce Wahr | Managing Director | Leadership |
Complete people profiles for CoAxia
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CoAxia
4 dated milestones of CoAxia across 14 years, from founding to its latest funding, stage changes and deals.
- Founded CoAxia is founded.
- Funding First funding round of $17.6M.
- Funding Latest funding round, Series D, of $22.5M.
- Exit Acquired by ZOLL AEDs.
Competitors of CoAxia
CoAxia has 2 listed competitors in our database, 2 of them funded. They include Sequent Medical and Metactive Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sequentmedical.com | 2007 | Aliso Viejo, United States | $65.26M | 1,028 | Catheter-based neurovascular devices for aneurysm treatment are developed. | |
| metactivemedical.com | 2011 | Olathe, United States | $4.7M | 31 | Endovascular devices are developed for peripheral and neurovascular disease treatments. |
Detailed competitors of CoAxia
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Neurology
3 companies that operate in the same segment as CoAxia (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CoAxia
CoAxia was founded in 1999 and raised its 1st funding round 5 years after it was founded.
CoAxia is headquartered in Maple Grove, United States. It is registered at Maple Grove, Minnesota, United States.
CoAxia is a funded company, having raised a total of $72.6M across 4 funding rounds to date. The company's 1st funding round was a Series B of $17.6M, raised on Jun 2004.
CoAxia was developing catheter-based perfusion augmentation therapies to improve outcomes for patients with cerebral ischemia. The core application for CoAxias catheter technology, under the trade names NeuroFlo and FloControl, involves the redistribution of blood flow from the lower extremities to support brain function during ischemia. Acquired by Zoll, an Asahi Kasei Group company in 2013.
CoAxia's top competitors include Sequent Medical and Metactive Medical.
CoAxia has 7 investors. Key investors include ZOLL AEDs, Canaan, Sofinnova, Affinity Capital Management, and Johnson & Johnson Innovation – JJDC.
CoAxia operates through Coaxia, Inc.
Yes. CoAxia was acquired by ZOLL AEDs in July 2013.